Product Program year 2025 Source: CMS Open Payments

Cellsearch

Device Diagnostic

Open in the dashboard

General payments

$44,292

17 payments

Research payments

$738,644

26 payments

Through program year 2025, $44,292 in general payments and $738,644 in research payments were reported against Cellsearch (Diagnostic).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2025 General $829 1
2025 Research $313 1
2022 Research $9,292 1
2021 General $4,207 1
2021 Research $373,099 20
2020 General $38,291 4
2020 Research $355,939 4
2019 General $965 11

Breakdown

Who paid General payments · program years 2019–2025
  1. Menarini Silicon Biosystems, Inc. $44,292 17 payments
Top recipients General payments · program year 2021
  1. Emmanuel Antonarakis Medical Oncology · Minneapolis, MN $4,207 100% · 1 payment

Each share is of general payments naming this product in 2021.

Specialties paid General payments · program year 2021
  1. Medical Oncology Internal Medicine $4,207 100% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2021
  1. Maryland $4,207 100% · 1 recipient

Each share is of general payments naming this product in 2021 where a state was reported.

17 general · 26 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record